CATALOGO DEI PRODOTTI DELLA RICERCA

BENINI, Anna
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 12.936
NA - Nord America 12.736
AS - Asia 6.256
SA - Sud America 791
Continente sconosciuto - Info sul continente non disponibili 327
AF - Africa 95
OC - Oceania 20
Totale 33.161
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.417
IT - Italia 5.174
SG - Singapore 2.707
RU - Federazione Russa 2.492
GB - Regno Unito 2.125
CN - Cina 1.829
BR - Brasile 635
FR - Francia 601
DE - Germania 543
SE - Svezia 506
VN - Vietnam 453
FI - Finlandia 451
HK - Hong Kong 432
IE - Irlanda 370
UA - Ucraina 209
KR - Corea 196
NL - Olanda 160
CA - Canada 144
JP - Giappone 103
IN - India 83
BD - Bangladesh 82
AR - Argentina 61
BE - Belgio 56
TR - Turchia 55
ES - Italia 50
ID - Indonesia 45
PL - Polonia 45
IR - Iran 37
MX - Messico 35
SA - Arabia Saudita 35
IQ - Iraq 34
PK - Pakistan 30
RO - Romania 30
CR - Costa Rica 27
CH - Svizzera 24
EC - Ecuador 22
GT - Guatemala 21
CO - Colombia 20
AU - Australia 18
CW - ???statistics.table.value.countryCode.CW??? 18
NG - Nigeria 18
ZA - Sudafrica 17
IL - Israele 16
TT - Trinidad e Tobago 16
CL - Cile 15
SV - El Salvador 15
HN - Honduras 13
LT - Lituania 13
CZ - Repubblica Ceca 12
EG - Egitto 12
AE - Emirati Arabi Uniti 11
UZ - Uzbekistan 11
VE - Venezuela 11
NI - Nicaragua 10
PE - Perù 10
PH - Filippine 10
AT - Austria 9
JO - Giordania 9
MA - Marocco 9
MY - Malesia 9
NP - Nepal 9
OM - Oman 9
TN - Tunisia 9
BG - Bulgaria 8
BO - Bolivia 8
JM - Giamaica 8
KE - Kenya 8
DZ - Algeria 7
EU - Europa 7
KZ - Kazakistan 7
PR - Porto Rico 7
PT - Portogallo 7
PY - Paraguay 7
QA - Qatar 7
TW - Taiwan 7
AZ - Azerbaigian 6
GP - Guadalupe 6
AL - Albania 5
BB - Barbados 5
BY - Bielorussia 5
DK - Danimarca 5
SC - Seychelles 5
AM - Armenia 4
EE - Estonia 4
ET - Etiopia 4
GR - Grecia 4
MK - Macedonia 4
PA - Panama 4
RS - Serbia 4
BZ - Belize 3
GE - Georgia 3
HR - Croazia 3
HU - Ungheria 3
LB - Libano 3
LU - Lussemburgo 3
TH - Thailandia 3
XK - ???statistics.table.value.countryCode.XK??? 3
DO - Repubblica Dominicana 2
LK - Sri Lanka 2
LY - Libia 2
Totale 32.831
Salva come PNG Salva come JPEG
Città #
Ashburn 1.983
Southend 1.764
Singapore 1.515
Jacksonville 1.502
Chandler 1.136
San Jose 836
Moscow 707
Woodbridge 686
Dallas 573
Ann Arbor 530
Verona 462
Hong Kong 421
Houston 371
Dublin 367
The Dalles 269
Council Bluffs 264
Milan 261
Rome 253
Beijing 220
New York 189
Lawrence 177
Princeton 177
Wilmington 177
Nanjing 151
Los Angeles 148
Ho Chi Minh City 143
Jinan 137
Shenyang 131
Sindelfingen 113
Hanoi 106
Tokyo 99
São Paulo 95
Santa Clara 91
Buffalo 90
Munich 89
Providence 89
Boardman 86
Helsinki 86
Bologna 85
Tianjin 82
Hebei 79
Naples 77
Ningbo 61
Changsha 59
Brussels 53
Seattle 50
Toronto 49
Zhengzhou 49
Florence 48
Haikou 48
Nanchang 47
Frankfurt am Main 46
Orem 46
Chicago 42
Turin 42
Atlanta 39
Columbus 39
Hangzhou 39
Guangzhou 36
Palermo 35
San Francisco 34
Jiaxing 33
Taizhou 31
Bari 30
Redondo Beach 29
Norwalk 28
Chennai 27
Lanzhou 26
Montreal 26
Redwood City 25
Da Nang 23
London 23
Napoli 23
Taiyuan 23
Warsaw 23
Genoa 22
Rio de Janeiro 22
Catania 21
Padova 21
Phoenix 21
Brooklyn 20
Jakarta 20
Riyadh 20
San José 20
Turku 20
Belo Horizonte 19
Fuzhou 19
Abuja 18
Amsterdam 18
Willemstad 18
Brasília 17
Genova 17
Guatemala City 17
Brescia 16
Cagliari 16
Denver 16
Fairfield 16
Lancaster 16
Torino 16
Washington 16
Totale 18.511
Salva come PNG Salva come JPEG
Nome #
Infezione da Klebsiella pneumoniae carbapenemasi produttrice: dati preliminari di dosaggio di tigeciclina, meropenem e colistina in plasma di pazienti ricoverati in terapia intensiva mediante cromatografia liquida ad alte prestazioni accoppiata a spettrometria di massa tandem 4.085
CEFTRIAXONE THERAPY, INTESTINAL BETA-LACTAMASES AND INTERACTION WITH PROBIOTICS IN CHILDREN 723
Proprietà farmacocinetiche e farmacodinamiche di antibiotici nel trattamento locale di infezioni protesiche 394
Influenza del sito d’ infezione (pancreas) sulla farmacocinetica e farmacodinamica di piperacillina-tazobactam 284
Variability in the release of antibiotics from PMMA bone cement spacers 284
Analysis of intestinal microflora of autistic children before and after probiotic treatment. 266
Antimicrobial activity of human pancreatic juice and its interaction with antibiotics. 262
Piperacillin-Tazobactam penetration into human pancreatic juice 244
Effetti del calcio policarbofil nel bambino con stipsi 242
Antibiotics penetration in human necrotizing pancreatitis (NP). 233
Health-promoting properties of new lactobacilli strains: in vivo models 230
Antibiotics and intestinal contents interaction 227
Safery and antibiotics concentrations in serum and urine after implantation of gentamicin-vancomycin-loaded spacers in patients with prosthetic joint infections 226
Expression of inducible nitric oxide synthase and cyclooxygenase-2 in human pancreas 224
Effetti dei fluorochinoloni in linfociti di pazienti in trattamenti protratti. 224
Commercial probiotic products: evaluation of microbial content and nomenclature 221
Farmacocinetica e farmacodinamica di piperacillina–tazobactam in pazienti con fistola pancreatica esterna 220
Diffusione ossea dell'associazione gentamicina-vancomicina da impianto in PMMA in osteomielite sperimentale 219
Effect of dose on the intestinal concentrations of fluoroquinolones. Infection and Intensive care. Italian and British Perspectives 218
Challenges and opportunities by bridging human and animal surveillance to tackle antimicrobial resistance 218
BACTERIAL ADHESION ON ANTIBIOTIC-LOADED POLYMETHYLMETHACRYLATE BONE CEMENT 217
Different probiotics and intestinal microflora in antibiotic treated children 214
Twice-weekly dapsone for primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1 infection: efficacy, safety and pharmacokinetic data 213
FLUOROQUINOLONES: EFFECTS OF DOSE ON INTESTINAL PENETRATION, HEPATIC ISOFORMS AND DNA DAMAGE IN RAT. 210
Antibiotics and their interaction with intestinal contents. 209
Antibiotici e pancreas esocrino: interazioni. 209
Antibiotic Release from removed temporary hip spacers 209
Evaluations of CYP 3A 4/5 and DNA damage in rat enterocytes and in human and rat lymphocytes by fluoroquinolones 208
Dynamics of SARS-CoV2 Infection and Multi-Drug Resistant Bacteria Superinfection in Patients With Assisted Mechanical Ventilation 205
Effect of pancreatic enzymes administration on intestinal ecosystem in patients with exocrine pancreatic insufficiency. Preliminary results 203
Rilascio locale dell’associazione gentamicina-vancomicina da chiodo endomidollare in osteomielite sperimentale 203
Rischio di nefrotossicità per terapia locale con cementi ossei antibiotati (aminoglicosidi e glicopeptidi) nelle infezioni protesiche. 203
Fluoroquinolones effects on patients lymphocytes during prolonged treatments 202
Interazione itraconazolo-ciprofloxacina nel compartimento intestinale del ratto: dati preliminari 202
Assessment of novel probiotic Lactobacillus casei strains strains for the production of functional dairy foods. 199
Antimicrobial activity of gentamicin and vancomycin combination in joint fluids after antibiotic-loaded cement spacer implantation in two-stage revision surgery. 198
Continuous Infusion of Flumazenil in the Management of Benzodiazepines Detoxification 197
Effect of ceftriaxone along with probiotics administrationon intestinal ecosystem and beta-lactamase activity 196
Effect of probiotics in the presence of antimicrobial therapy 195
Bacterial faecal flora in healthy women of different ages. 194
FLUOROQUINOLONES: EFFECTS OF DOSE ON INTESTINAL PENETRATION, HEPATIC ISOFORM AND DNA DAMAGE IN RAT. 194
EFFETTI DI FLUOROCHINOLONI IN LINFOCITI DI PAZIENTI IN TRATTAMENTI PROTRATTI. 194
Fluoroquinolones (FQs) effects on enterocytes and lymphocytes. 193
Prophylaxis of P. carinii pneumonia (PCP). in HIV-infected patients with trimethoprim/sulfametoxazole (TMP/SMX) or dapsone (DDS) 192
Bacterial adhesion on antibiotic-loaded polymethylmethacrylate bone cement 188
Itraconazole-ciprofloxacin interaction on the pharmacokinetics of the intestinal compartment: preliminary results in rats 187
Bacterial flora composition and faecal enzymes in pre- and postmenopausal women with breast cancer. 185
Dose-effect of fluoroquinolones on intestinal penetration, hepatic isoforms and DNA damage in the rat 185
Vancogenx-space for hip and knee: gentamicin and vancomycin levels in serum and urine from a multicenter trial 185
Health-promoting properties of new lactobacilli strains: in-vivo models 183
Health promoting of new Lactobacilli strains: in-vivo models. 182
Effetti sistemici ed intestinali dei fluorochinoloni 180
Attività antimicrobica del siero di pazienti cancerosi ed interazioni farmacologiche con diversi farmaci antibatterici 178
A serum antimicrobial activity of cancer patients and interaction with different antibacterial drugs. 177
A different behaviour of antibiotics in presence of fresh intestinal content in vitro. 175
Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in pancreatic cancer 175
Antibiotic release from removed temporary hip spacers 175
Metronidazole (MZ) penetration into pancreatic juice (P5) and necrotic pancreatic tissue (NPT). 174
Valutazione della compliance al dapsone (DDS) in pazienti in profilassi per PCP. 173
Changes in rat intestinal microflora following oral and parenteral administration of antimicrobial drugs 171
Microflora intestinale ed enzimi fecali in donne con fibromatosi uterina e tumore al seno. 171
Alterazioni dell’ecosistema inestinale da antibiotici. problemi e prospettive 170
Expression of inducible nitric oxide synthase and cyclooxygenase-2 in pancreatic cancer. 170
Release of gentamicin and vancomycin alone and in combination from polymethylmethacrylate (PMMA) cement 168
Behaviour of ciprofloxacin intestinal pharmacokinetics after different timing of Itraconazole administration 168
Commercial probiotic products: evaluation of microbial content and nomenclature. 167
Release of gentamicin and vancomycin from preformed spacers in infected total hip arthroplasties: Measurement of concentrations and inhibitory activity in patients' drainage fluids and serum 167
Intestinal ecosystem and metabolic capacity in women with breast cancer 166
Variability in the release of antibiotics from PMMA bone cement spacers 166
Interleuchina –4 e ossido nitrico nella pancreatite cronica umana. 164
Preliminary evaluation of probiotic properties of L. casei strains 164
Microbiological and pharmacological tests on new antibiotic-loaded PMMA-based composites for the treatment of osteomyelitis 164
Behaviour of antibiotics during human necrotizing pancreatitis. 163
Rilascio di antibiotici da spaziatori antibiotati nei fluidi di drenaggio 163
Different effect of pre-treatment with phenobarbital on transintestinal elimination of moxifloxacin and ciprofloxacin: preliminary data 163
Effects of itraconazole on the pharmacokinetics of ciprofloxacin and the intestinal metabolizing system (CYP450 and P-glycoprotein) 163
Twice-weekly dapsone for primary prophylaxis of Pneumocystis carinii pneumonia in HIV-1 infection: comparative efficacy and pharmacokinetic data. 161
Modulation of the intestinal ecosystem by probiotics and lactulose in children during treatment with ceftriazone 161
Release of antibiotics from polymethylmethacrylate cement 160
Interazione positiva fra succo pancreatico e antibatterici. 160
Potential probiotics benefit in gastrointestinal disorders of different aetiology. 160
Premenstrual syndrome (PMS): effect of probiotic supplement and S-adenosyl-L-methionine (SAMe) on intestinal microflora. 158
Pk-pd parameters ratio of antibotics released from antibiotic-loaded spacers in drainage fluids. 158
Effetto del trattamento con fluochinoloni su linfociti di pazienti in politerapia prolungata 158
Formazione in PNCAR 158
Improvement of intestinal balance in chronic pancreatitis insufficiency (CPI) by antibiotic and probiotic administration. 156
Composition and metabolic activity of the intestinal microflora in pre- and postmenopausal women with breast cancer 156
Intestinal microflora composition in premenstrual syndrome (PMS) and effect of Lactobacillus-Bifidobacterium administration 155
Attività degli antibiotici nei sistemi biologici 155
DRAINAGE AND SERUM LEVELS OF ANTIBIOTICS FOLLOWING TEMPORARY SPACER IMPLANTS IN TWO-STAGE REVISION SURGERY 154
Pefloxacin penetration into human necrotic pancreatic tissue. 154
Trattamento con fluorochinoloni ed effetti su linfociti di pazienti in politerapia prolungata 154
Attività degli antibiotici nei sistemi biologici 153
Immunosuppression and antimicrobial drugs: effects on rats intestinal microflora. 152
Rilascio di antibiotici da spaziatori espiantati 152
Effect of gluten-free diet on faecal microflora composition of women with coeliac disease 152
Label and plate counting correspondence of probiotic products 151
Effects on intestinal microflora during systemic antimicrobial prophylaxis in orthopaedic patients: teicoplanin (TC) vs cefalozin (CZ). 150
Behavior of antibiotics during human necrotizing pancreatitis. 150
Attività in vitro e in vivo di antibiotici nelle infezioni del pancreas. In: “Metodi innovativi in farmacologia” 149
Totale 23.360
Salva come PNG Salva come JPEG
Categoria #
all - tutte 94.698
article - articoli 35.595
book - libri 0
conference - conferenze 54.885
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 4.218
Totale 189.396
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022855 0 0 0 0 60 55 46 76 70 61 134 353
2022/20233.386 266 285 353 540 314 674 64 252 307 50 188 93
2023/20241.949 85 159 136 254 198 237 120 206 49 105 224 176
2024/20253.993 291 391 205 583 285 83 187 203 617 197 243 708
2025/20268.703 676 411 621 1.243 2.066 790 936 458 624 524 172 182
2026/20273.418 700 270 663 1.726 59 0 0 0 0 0 0 0
Totale 33.161